Cargando…
Case Report: Mucolipidosis II and III Alpha/Beta Caused by Pathogenic Variants in the GNPTAB Gene (Mucolipidosis)
OBJECTIVE: This study aimed to improve the cognition of mucolipidosis (ML) II and III alpha/beta by analyzing the clinical manifestations of two patients. METHODS: The clinical, biochemical, and molecular data of two clinical cases associated with ML II and III alpha/beta were analyzed and compared...
Autores principales: | Mao, Shao-Jia, Zu, Yu-Mei, Dai, Yang-Li, Zou, Chao-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033252/ https://www.ncbi.nlm.nih.gov/pubmed/35463894 http://dx.doi.org/10.3389/fped.2022.852701 |
Ejemplares similares
-
Outcomes after HSCT for mucolipidosis II (I-cell disease) caused by novel compound heterozygous GNPTAB mutations
por: He, Si-jia, et al.
Publicado: (2023) -
Mucolipidosis Type II Secondary to GNPTAB Gene Deletion from India
por: Gowda, Vykuntaraju K., et al.
Publicado: (2017) -
GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report
por: Ho, Chi-Chun, et al.
Publicado: (2018) -
A GNPTAB nonsense variant is associated with feline mucolipidosis II (I-cell disease)
por: Wang, Ping, et al.
Publicado: (2018) -
Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
por: Essawi, Mona L., et al.
Publicado: (2021)